With a six-month beta of 0.7686, Divis Labs is characterized by low volatility, making it a potentially stable investment. On the last trading day, Divis Labs closed at Rs 5620.45, with no percentage ...

Canara Robeco Equity Hybrid Fund (IDCW-M) 101.17 1,80,000 1.02 Canara Robeco Equity Hybrid Fund (G) 101.17 1,80,000 1.02 Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) 101.17 1,80,000 1.02 Canara ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Divis Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. The Company is one ...

Here's the list of Divis Lab.'s futures contracts. The future contract comprises financial derivative contracts that bind parties to buy and sell an asset at a specified future timeand price.

Divis Laboratories Limited is among India’s leading pharmaceutical companies. The firm is headquartered in Hyderabad, Andhra Pradesh. Divis Laboratories is primarily known for the production of ...

Divis Labs concluded the previous trading day at a closing price of Rs 5516.55, reflecting the latest market activity. Divis Labs has recorded a six-month beta of 0.7686, reflecting its consistent ...

9 min read. Updated: 25 Feb 2025, 06:01 PM IST ...

Divis Laboratories Ltd witnessed volume of 24583 shares by 10:47 IST on BSE, a 8.7 times surge over two-week average daily volume of 2824 shares IndusInd Bank Ltd, Axis Bank Ltd, Gujarat State ...

The short-term outlook is bullish for Divi’s Laboratories. The stock has moved up very well over the last couple of days after taking support from the 200-Day Moving Average (DMA). This 200-DMA ...

The ICAI may review IndusInd Bank's financial statements after discrepancies in accounting to the tune of Rs 2,100 crore were found. The bank's derivatives portfolio is under scrutiny for a... India's ...